According to GlobalData’s medical device pipeline database, 23 Intrauterine Devices (IUDs) devices are in various stages of development globally. GlobalData’s report Intrauterine Devices (IUDs) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 12 are in active development, while the remaining 11 are in an inactive stage of development. There are five products in the early stages of development, and the remaining seven are in the late stages of development.
An Intrauterine Device (IUD) is a small T-shaped device inserted into the uterus to prevent pregnancy. Intrauterine Device (IUD) is considered to be a form of long-acting reversible contraceptive since it can remain inserted for 5-10 years. IUDs use either copper or hormones to prevent pregnancy. One unit refers to one IUD.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Intrauterine Devices (IUDs) pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Intrauterine Devices (IUDs) devices. Overall, most of these Intrauterine Devices (IUDs) pipeline devices are being developed by private entities.
Key players involved in the active development of Intrauterine Devices (IUDs) include Teva Pharmaceuticals USA, OCON Medical, Sebela Pharmaceuticals, Bayer, Contrel Europe, HLL Lifecare, Laboratoire HRA Pharma, Merck, Merck Serono and Bioceptive.
For a complete picture of the developmental pipeline for Intrauterine Devices (IUDs) devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.